Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research from Department of Physiology, Anatomy & Genetics provides new evidence that some cases of Congenital Heart Defect (CHD) may be caused by a combination of genetic and environmental factors.

© Shutterstock

Congenital heart disease is a heart defect that a baby is born with. It is the most common type of birth defect, affecting 1 in 100 babies worldwide, with about 12 affected babies born each day in the UK. Untreated, more than half of these will die. Such defects occur because something goes wrong as the baby’s heart forms in the womb. This can be because of faulty genes inherited from the parents, or it can be caused by environmental factors affecting the mother during pregnancy.

Most research in this area over the past 20 years has focused on understanding the genetic causes of CHD. However, even though the latest genome sequencing technologies have identified mutations in over 100 genes that can cause CHD, still only 20-30% of cases can be explained genetics alone.

Read more (Department of Physiology, Anatomy & Genetics website)

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.